FDA vs NMPA: US and China Medical Device Regulation Compared
Side-by-side comparison of FDA and NMPA medical device registration — classification, CMDE review, MAH requirements, clinical trials, and timelines.
FDA
U.S. Food and Drug Administration
United States
The FDA is the primary regulatory authority for medical devices in the United States. Its Center for Devices and Radiological Health (CDRH) oversees premarket review, postmarket surveillance, and enfo…
Class I, II, III
510(k), PMA, De Novo, HDE
- ▸510(k) clearance and PMA approval
- ▸MAUDE adverse event database
- ▸FDA Enforcement Reports and recalls
- ▸De Novo classification
- ▸Breakthrough Device Designation
NMPA
National Medical Products Administration (China)
China
China's NMPA regulates medical devices through CMDE (Center for Medical Device Evaluation) technical reviews. China uses a three-class risk-based system. Foreign manufacturers must appoint a Marketing…
Class I, II, III
NMPA Registration (CMDE review)
- ▸CMDE technical review
- ▸MAH (Marketing Authorization Holder) system
- ▸In-country testing requirements
- ▸Clinical trial oversight
- ▸NMPA registration certificates
MedFlux monitors both FDA and NMPA in real time — every regulatory change, safety alert, and market signal delivered in under 90 seconds.
COMPARE LIVE DATA FREE →§ OTHER COMPARISONS
Compare FDA 510(k)/PMA with EU MDR CE marking — classification, timelines, costs, QMS requirements, …
FDA vs PMDACompare FDA 510(k)/PMA with PMDA Shonin/Ninsho — classification, QMS (Ordinance 169 vs 21 CFR 820), …
EMA vs NMPACompare EU MDR CE marking with NMPA registration — Notified Bodies vs CMDE, UDI requirements, clinic…
FDA vs TGACompare FDA and TGA medical device pathways — ARTG registration, MDSAP recognition, classification d…